Coenzyme Q10: A Biomarker in the Differential Diagnosis of Parkinsonian Syndromes.

Antioxidants (Basel) · 2023 · PMC10740444 · PMID 38136223

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

The decreases in plasma CoQ10 levels in patients with MSA did not reach statistical significance compared to patients with PD and PSP ( Figure 1 A).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.